Medical Grade Chitosan Market in Southeast Asia - Manufacturing and Consumption, Outlook and Forecast 2020-2026

April 2020 | 107 pages | ID: M81BC03D205CEN
Market Monitor Global

Abstracts

Chitosan (CS) is a linear polysaccharide which is achieved by deacetylation of chitin, which is the second most plentiful compound in nature, after cellulose. Chitosan was applied in pharmaceutics/drug/gene delivery and cell encapsulation. Chitosan was applied in binding to protein drugs, contact lenses and implants. GMP grade chitosan covers chitosan for a variety of medical applications.

This report contains market size and forecasts of Medical Grade Chitosan in Southeast Asia, including the following market information:
Southeast Asia Medical Grade Chitosan Market Revenue, 2015-2020, 2021-2026, ($ millions)
Southeast Asia Medical Grade Chitosan Market Consumption, 2015-2020, 2021-2026, (Ton)
Southeast Asia Medical Grade Chitosan Production Capacity, 2015-2020, 2021-2026, (Ton)
Top Five Competitors in Southeast Asia Medical Grade Chitosan Market 2019 (%)
The global Medical Grade Chitosan market was valued at 30 million in 2019 and is projected to reach US$ 40 million by 2026, at a CAGR of 7.4% during the forecast period. While the Medical Grade Chitosan market size in Southeast Asia was US$ XX million in 2019, and it is expected to reach US$ XX million by the end of 2026, with a CAGR of XX% during 2020-2026.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Medical Grade Chitosan manufacturers, suppliers, distributors and industry experts on the impacts of the COVID-19 pandemic on businesses, with top challenges including ingredients and raw material delays, component and packaging shortages, reduced/cancelled orders from clients and consumers, and closures of production lines in some impacted areas.
This report also analyses and evaluates the COVID-19 impact on Medical Grade Chitosan production and consumption in Southeast Asia

Total Market by Segment:

Southeast Asia Medical Grade Chitosan Market, By Type, 2015-2020, 2021-2026 ($ millions) & (Ton)
Southeast Asia Medical Grade Chitosan Market Segment Percentages, By Type, 2019 (%)

• Animal Origin Chitosan
• Plant Based Chitosan

Southeast Asia Medical Grade Chitosan Market, By Application, 2015-2020, 2021-2026 ($ millions) & (Ton)
Southeast Asia Medical Grade Chitosan Market Segment Percentages, By Application, 2019 (%)

• Wound Care
• Healthcare Products
• Antibacterial Products
• Others

Competitor Analysis

The report also provides analysis of leading market participants including:
Total Medical Grade Chitosan Market Competitors Revenues in Southeast Asia, by Players 2015-2020 (Estimated), ($ millions)
Total Medical Grade Chitosan Market Competitors Revenues Share in Southeast Asia, by Players 2019 (%)
Total Southeast Asia Medical Grade Chitosan Market Competitors Sales, by Players 2015-2020 (Estimated), (Ton)
Total Southeast Asia Medical Grade Chitosan Market Competitors Sales Market Share by Players 2019 ($ millions)

Further, the report presents profiles of competitors in the market, including the following:

• Primex
• KitoZyme
• BIO21
• YSK
• Vietnam Food
• NovaMatrix
• KIMICA
• Ningbo Zhenhai Haixin Biological
• Golden-Shell Pharmaceutical
• Zhejiang Fengrun Biotech
• Jiangsu Shuanglin
• Jiangsu Aoxin Biotechnology

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Medical Grade Chitosan Market Definition
1.2 Market Segments
  1.2.1 Segment by Type
  1.2.2 Segment by Application
1.3 Southeast Asia Medical Grade Chitosan Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 COVID-19 IMPACT: SOUTHEAST ASIA MEDICAL GRADE CHITOSAN OVERALL MARKET SIZE

2.1 Southeast Asia Medical Grade Chitosan Market Size: 2020 VS 2026
2.2 Southeast Asia Medical Grade Chitosan Revenue, Prospects & Forecasts: 2015-2026
2.3 Southeast Asia Medical Grade Chitosan Sales (Consumption): 2015-2026

3 COMPANY LANDSCAPE

3.1 Top Medical Grade Chitosan Players in Southeast Asia (including Foreign and Local Companies)
3.2 Top Southeast Asia Medical Grade Chitosan Companies Ranked by Revenue
3.3 Southeast Asia Medical Grade Chitosan Revenue by Companies (including Foreign and Local Companies)
3.4 Southeast Asia Medical Grade Chitosan Sales by Companies (including Foreign and Local Companies)
3.5 Southeast Asia Medical Grade Chitosan Price by Manufacturer (2015-2020)
3.6 Top 3 and Top 5 Medical Grade Chitosan Companies in Southeast Asia, by Revenue in 2019
3.7 Southeast Asia Manufacturers Medical Grade Chitosan Product Type
3.8 Tier 1, Tier 2 and Tier 3 Medical Grade Chitosan Players in Southeast Asia
  3.8.1 List of Southeast Asia Tier 1 Medical Grade Chitosan Companies
  3.8.2 List of Southeast Asia Tier 2 and Tier 3 Medical Grade Chitosan Companies

4 SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 By Type - Southeast Asia Medical Grade Chitosan Market Size Markets, 2020 & 2026
  4.1.2 Animal Origin Chitosan
  4.1.3 Plant Based Chitosan
4.2 By Type - Southeast Asia Medical Grade Chitosan Revenue & Forecasts
  4.2.1 By Type - Southeast Asia Medical Grade Chitosan Revenue, 2015-2020
  4.2.2 By Type - Southeast Asia Medical Grade Chitosan Revenue, 2021-2026
  4.2.3 By Type - Southeast Asia Medical Grade Chitosan Revenue Market Share, 2015-2026
4.3 By Type - Southeast Asia Medical Grade Chitosan Sales & Forecasts
  4.3.1 By Type - Southeast Asia Medical Grade Chitosan Sales, 2015-2020
  4.3.2 By Type - Southeast Asia Medical Grade Chitosan Sales, 2021-2026
  4.3.3 By Type - Southeast Asia Medical Grade Chitosan Sales Market Share, 2015-2026
4.4 By Type - Southeast Asia Medical Grade Chitosan Price (Manufacturers Selling Prices), 2015-2026

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Southeast Asia Medical Grade Chitosan Market Size, 2020 & 2026
  5.1.2 Wound Care
  5.1.3 Healthcare Products
  5.1.4 Antibacterial Products
  5.1.5 Others
5.2 By Application - Southeast Asia Medical Grade Chitosan Revenue & Forecasts
  5.2.1 By Application - Southeast Asia Medical Grade Chitosan Revenue, 2015-2020
  5.2.2 By Application - Southeast Asia Medical Grade Chitosan Revenue, 2021-2026
  5.2.3 By Application - Southeast Asia Medical Grade Chitosan Revenue Market Share, 2015-2026
5.3 By Application - Southeast Asia Medical Grade Chitosan Sales & Forecasts
  5.3.1 By Application - Southeast Asia Medical Grade Chitosan Sales, 2015-2020
  5.3.2 By Application - Southeast Asia Medical Grade Chitosan Sales, 2021-2026
  5.3.3 By Application - Southeast Asia Medical Grade Chitosan Sales Market Share, 2015-2026
5.4 By Application - Southeast Asia Medical Grade Chitosan Price (Manufacturers Selling Prices), 2015-2026

6 MANUFACTURERS & BRANDS PROFILES

6.1 Primex
  6.1.1 Primex Corporate Summary
  6.1.2 Primex Business Overview
  6.1.3 Primex Medical Grade Chitosan Major Product Offerings
  6.1.4 Primex Sales and Revenue in Southeast Asia (2015-2020)
  6.1.5 Primex Key News
6.2 KitoZyme
  6.2.1 KitoZyme Corporate Summary
  6.2.2 KitoZyme Business Overview
  6.2.3 KitoZyme Medical Grade Chitosan Major Product Offerings
  6.2.4 KitoZyme Sales and Revenue in Southeast Asia (2015-2020)
  6.2.5 KitoZyme Key News
6.3 BIO21
  6.3.1 BIO21 Corporate Summary
  6.3.2 BIO21 Business Overview
  6.3.3 BIO21 Medical Grade Chitosan Major Product Offerings
  6.3.4 BIO21 Sales and Revenue in Southeast Asia (2015-2020)
  6.3.5 BIO21 Key News
6.4 YSK
  6.4.1 YSK Corporate Summary
  6.4.2 YSK Business Overview
  6.4.3 YSK Medical Grade Chitosan Major Product Offerings
  6.4.4 YSK Sales and Revenue in Southeast Asia (2015-2020)
  6.4.5 YSK Key News
6.5 Vietnam Food
  6.5.1 Vietnam Food Corporate Summary
  6.5.2 Vietnam Food Business Overview
  6.5.3 Vietnam Food Medical Grade Chitosan Major Product Offerings
  6.5.4 Vietnam Food Sales and Revenue in Southeast Asia (2015-2020)
  6.5.5 Vietnam Food Key News
6.6 NovaMatrix
  6.6.1 NovaMatrix Corporate Summary
  6.6.2 NovaMatrix Business Overview
  6.6.3 NovaMatrix Medical Grade Chitosan Major Product Offerings
  6.6.4 NovaMatrix Sales and Revenue in Southeast Asia (2015-2020)
  6.6.5 NovaMatrix Key News
6.7 KIMICA
  6.6.1 KIMICA Corporate Summary
  6.6.2 KIMICA Business Overview
  6.6.3 KIMICA Medical Grade Chitosan Major Product Offerings
  6.4.4 KIMICA Sales and Revenue in Southeast Asia (2015-2020)
  6.7.5 KIMICA Key News
6.8 Ningbo Zhenhai Haixin Biological
  6.8.1 Ningbo Zhenhai Haixin Biological Corporate Summary
  6.8.2 Ningbo Zhenhai Haixin Biological Business Overview
  6.8.3 Ningbo Zhenhai Haixin Biological Medical Grade Chitosan Major Product Offerings
  6.8.4 Ningbo Zhenhai Haixin Biological Sales and Revenue in Southeast Asia (2015-2020)
  6.8.5 Ningbo Zhenhai Haixin Biological Key News
6.9 Golden-Shell Pharmaceutical
  6.9.1 Golden-Shell Pharmaceutical Corporate Summary
  6.9.2 Golden-Shell Pharmaceutical Business Overview
  6.9.3 Golden-Shell Pharmaceutical Medical Grade Chitosan Major Product Offerings
  6.9.4 Golden-Shell Pharmaceutical Sales and Revenue in Southeast Asia (2015-2020)
  6.9.5 Golden-Shell Pharmaceutical Key News
6.10 Zhejiang Fengrun Biotech
  6.10.1 Zhejiang Fengrun Biotech Corporate Summary
  6.10.2 Zhejiang Fengrun Biotech Business Overview
  6.10.3 Zhejiang Fengrun Biotech Medical Grade Chitosan Major Product Offerings
  6.10.4 Zhejiang Fengrun Biotech Sales and Revenue in Southeast Asia (2015-2020)
  6.10.5 Zhejiang Fengrun Biotech Key News
6.11 Jiangsu Shuanglin
  6.11.1 Jiangsu Shuanglin Corporate Summary
  6.11.2 Jiangsu Shuanglin Medical Grade Chitosan Business Overview
  6.11.3 Jiangsu Shuanglin Medical Grade Chitosan Major Product Offerings
  6.11.4 Jiangsu Shuanglin Sales and Revenue in Southeast Asia (2015-2020)
  6.11.5 Jiangsu Shuanglin Key News
6.12 Jiangsu Aoxin Biotechnology
  6.12.1 Jiangsu Aoxin Biotechnology Corporate Summary
  6.12.2 Jiangsu Aoxin Biotechnology Medical Grade Chitosan Business Overview
  6.12.3 Jiangsu Aoxin Biotechnology Medical Grade Chitosan Major Product Offerings
  6.12.4 Jiangsu Aoxin Biotechnology Sales and Revenue in Southeast Asia (2015-2020)
  6.12.5 Jiangsu Aoxin Biotechnology Key News
6.13 Qingdao Yunzhou Biochemistry
  6.13.1 Qingdao Yunzhou Biochemistry Corporate Summary
  6.13.2 Qingdao Yunzhou Biochemistry Medical Grade Chitosan Business Overview
  6.13.3 Qingdao Yunzhou Biochemistry Medical Grade Chitosan Major Product Offerings
  6.13.4 Qingdao Yunzhou Biochemistry Sales and Revenue in Southeast Asia (2015-2020)
  6.13.5 Qingdao Yunzhou Biochemistry Key News

7 MEDICAL GRADE CHITOSAN PRODUCTION CAPACITY, EXPORT AND IMPORT ANALYSIS

7.1 Medical Grade Chitosan Production Capacity and Value in Southeast Asia, Situation Analysis and Prediction, 2015-2026
  7.1.1 Southeast Asia Medical Grade Chitosan Production Capacity, 2015-2026
  7.1.2 Southeast Asia Medical Grade Chitosan Production 2015-2026
  7.1.3 Southeast Asia Medical Grade Chitosan Production Value 2015-2026
7.2 Key Local Medical Grade Chitosan Manufacturers in Southeast Asia
  7.2.1 Southeast Asia Key Local Medical Grade Chitosan Manufacturers Production Capacity
  7.2.2 Southeast Asia Key Local Medical Grade Chitosan Manufacturers Production
  7.2.3 Southeast Asia Key Local Medical Grade Chitosan Manufacturers Production Value
  7.2.4 The Proportion of Medical Grade Chitosan Production Sold in Southeast Asia and Sold Other Than Southeast Asia by Manufacturers
7.3 Medical Grade Chitosan Export and Import in Southeast Asia
  7.3.1 Southeast Asia Medical Grade Chitosan Export Market
  7.3.2 Southeast Asia Medical Grade Chitosan Source of Imports

8 COVID-19 IMPACT: KEY MARKET TRENDS, OPPORTUNITY, DRIVERS AND RESTRAINTS

8.1 PESTLE Analysis for Southeast Asia Medical Grade Chitosan Market
8.2 Market Opportunities & Trends
8.3 Market Drivers
8.4 Market Restraints

9 COVID-19 IMPACT ON MEDICAL GRADE CHITOSAN SUPPLY CHAIN ANALYSIS

9.1 Supply Chain Analysis
9.2 Upstream Market Analysis
9.3 Downstream and Clients Market Analysis
9.4 Marketing Channels Analysis
  9.4.1 Marketing Channels
  9.4.2 Medical Grade Chitosan Distributors and Sales Agents in Southeast Asia

10 CONCLUSION

11 APPENDIX

11.1 Note
11.2 Examples of Clients
11.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Key Players of Medical Grade Chitosan in Southeast Asia
Table 2. Top Players in Southeast Asia, Ranking by Revenue (2019)
Table 3. Southeast Asia Medical Grade Chitosan Revenue by Companies, (US$, Mn), 2015-2020
Table 4. Southeast Asia Medical Grade Chitosan Revenue Share by Companies, 2015-2020
Table 5. Southeast Asia Medical Grade Chitosan Sales by Companies, (Ton), 2015-2020
Table 6. Southeast Asia Medical Grade Chitosan Sales Share by Companies, 2015-2020
Table 7. Key Manufacturers Medical Grade Chitosan Price (2015-2020) (US$/Kg)
Table 8. Southeast Asia Manufacturers Medical Grade Chitosan Product Type
Table 9. List of Southeast Asia Tier 1 Medical Grade Chitosan Companies, Revenue (US$, Mn) in 2019 and Market Share
Table 10. List of Southeast Asia Tier 2 and Tier 3 Medical Grade Chitosan Companies, Revenue (US$, Mn) in 2019 and Market Share
Table 11. By Type - Medical Grade Chitosan Revenue in Southeast Asia (US$, Mn), 2015-2020
Table 12. By Type - Medical Grade Chitosan Revenue in Southeast Asia (US$, Mn), 2021-2026
Table 13. By Type - Medical Grade Chitosan Sales in Southeast Asia (Ton), 2015-2020
Table 14. By Type - Medical Grade Chitosan Sales in Southeast Asia (Ton), 2021-2026
Table 15. By Application - Medical Grade Chitosan Revenue in Southeast Asia, (US$, Mn), 2015-2020
Table 16. By Application - Medical Grade Chitosan Revenue in Southeast Asia, (US$, Mn), 2021-2026
Table 17. By Application - Medical Grade Chitosan Sales in Southeast Asia, (Ton), 2015-2020
Table 18. By Application - Medical Grade Chitosan Sales in Southeast Asia, (Ton), 2021-2026
Table 19. Primex Corporate Summary
Table 20. Primex Medical Grade Chitosan Product Offerings
Table 21. Primex Medical Grade Chitosan Sales (Ton), Revenue (US$, Mn) and Average Price (US$/Kg) (2015-2020)
Table 22. KitoZyme Corporate Summary
Table 23. KitoZyme Medical Grade Chitosan Product Offerings
Table 24. KitoZyme Medical Grade Chitosan Sales (Ton), Revenue (US$, Mn) and Average Price (US$/Kg) (2015-2020)
Table 25. BIO21 Corporate Summary
Table 26. BIO21 Medical Grade Chitosan Product Offerings
Table 27. BIO21 Medical Grade Chitosan Sales (Ton), Revenue (US$, Mn) and Average Price (US$/Kg) (2015-2020)
Table 28. YSK Corporate Summary
Table 29. YSK Medical Grade Chitosan Product Offerings
Table 30. YSK Medical Grade Chitosan Sales (Ton), Revenue (US$, Mn) and Average Price (US$/Kg) (2015-2020)
Table 31. Vietnam Food Corporate Summary
Table 32. Vietnam Food Medical Grade Chitosan Product Offerings
Table 33. Vietnam Food Medical Grade Chitosan Sales (Ton), Revenue (US$, Mn) and Average Price (US$/Kg) (2015-2020)
Table 34. NovaMatrix Corporate Summary
Table 35. NovaMatrix Medical Grade Chitosan Product Offerings
Table 36. NovaMatrix Medical Grade Chitosan Sales (Ton), Revenue (US$, Mn) and Average Price (US$/Kg) (2015-2020)
Table 37. KIMICA Corporate Summary
Table 38. KIMICA Medical Grade Chitosan Product Offerings
Table 39. KIMICA Medical Grade Chitosan Sales (Ton), Revenue (US$, Mn) and Average Price (US$/Kg) (2015-2020)
Table 40. Ningbo Zhenhai Haixin Biological Corporate Summary
Table 41. Ningbo Zhenhai Haixin Biological Medical Grade Chitosan Product Offerings
Table 42. Ningbo Zhenhai Haixin Biological Medical Grade Chitosan Sales (Ton), Revenue (US$, Mn) and Average Price (US$/Kg) (2015-2020)
Table 43. Golden-Shell Pharmaceutical Corporate Summary
Table 44. Golden-Shell Pharmaceutical Medical Grade Chitosan Product Offerings
Table 45. Golden-Shell Pharmaceutical Medical Grade Chitosan Sales (Ton), Revenue (US$, Mn) and Average Price (US$/Kg) (2015-2020)
Table 46. Zhejiang Fengrun Biotech Corporate Summary
Table 47. Zhejiang Fengrun Biotech Medical Grade Chitosan Product Offerings
Table 48. Zhejiang Fengrun Biotech Medical Grade Chitosan Sales (Ton), Revenue (US$, Mn) and Average Price (US$/Kg) (2015-2020)
Table 49. Jiangsu Shuanglin Corporate Summary
Table 50. Jiangsu Shuanglin Medical Grade Chitosan Product Offerings
Table 51. Jiangsu Shuanglin Medical Grade Chitosan Sales (Ton), Revenue (US$, Mn) and Average Price (US$/Kg) (2015-2020)
Table 52. Jiangsu Aoxin Biotechnology Corporate Summary
Table 53. Jiangsu Aoxin Biotechnology Medical Grade Chitosan Product Offerings
Table 54. Jiangsu Aoxin Biotechnology Medical Grade Chitosan Sales (Ton), Revenue (US$, Mn) and Average Price (US$/Kg) (2015-2020)
Table 55. Qingdao Yunzhou Biochemistry Corporate Summary
Table 56. Qingdao Yunzhou Biochemistry Medical Grade Chitosan Product Offerings
Table 57. Qingdao Yunzhou Biochemistry Medical Grade Chitosan Sales (Ton), Revenue (US$, Mn) and Average Price (US$/Kg) (2015-2020)
Table 58. Medical Grade Chitosan Production Capacity (Ton) of Local Manufacturers in Southeast Asia, 2015-2020
Table 59. Medical Grade Chitosan Production (Ton) of Local Manufacturers in Southeast Asia, 2015-2020
Table 60. Southeast Asia Medical Grade Chitosan Production Market Share of Local Manufacturers, 2015-2020
Table 61. Medical Grade Chitosan Production Value (US$, Mn) of Local Manufacturers in Southeast Asia, 2015-2020
Table 62. Southeast Asia Medical Grade Chitosan Production Value Market Share of Local Manufacturers, 2015-2020
Table 63. The Percentage of Medical Grade Chitosan Production Sold in Southeast Asia and Sold Other Than Southeast Asia by Manufacturers
Table 64. The Percentage of Medical Grade Chitosan Production Sold in Southeast Asia and Sold Other Than Southeast Asia by Manufacturers
Table 65. Dangeguojia Medical Grade Chitosan Sales (Consumption), Production, Export and Import, 2015-2020
Table 66. Raw Materials and Suppliers
Table 67. Medical Grade Chitosan Downstream Clients in Southeast Asia
Table 68. Medical Grade Chitosan Distributors and Sales Agents in Southeast Asia

List Of Figures

LIST OF FIGURES

Figure 1. Medical Grade Chitosan Segment by Type
Figure 2. Medical Grade Chitosan Segment by Application
Figure 3. Dangeguojia Medical Grade Chitosan Market Overview: 2020
Figure 4. Key Caveats
Figure 5. Medical Grade Chitosan Market Size in Southeast Asia, (US$, Mn) & (Ton): 2020 VS 2026
Figure 6. Southeast Asia Medical Grade Chitosan Revenue, 2015-2026 (US$, Mn)
Figure 7. Medical Grade Chitosan Sales in Southeast Asia: 2015-2026 (Ton)
Figure 8. The Top 3 and 5 Players Market Share by Medical Grade Chitosan Revenue in 2019
Figure 9. By Type - Southeast Asia Medical Grade Chitosan Incremental Growth, (US$, Mn), 2015-2026
Figure 10. By Type - Southeast Asia Medical Grade Chitosan Market Share, 2015-2020
Figure 11. By Type - Southeast Asia Medical Grade Chitosan Market Share, 2020-2026
Figure 12. By Type - Southeast Asia Medical Grade Chitosan Price (US$/Kg), 2015-2026
Figure 13. By Application - Medical Grade Chitosan Revenue in Southeast Asia (US$, Mn), 2020 & 2026
Figure 14. By Application - Southeast Asia Medical Grade Chitosan Market Share, 2015-2020
Figure 15. By Application - Southeast Asia Medical Grade Chitosan Market Share, 2020-2026
Figure 16. By Application -Southeast Asia Medical Grade Chitosan Price (US$/Kg), 2015-2026
Figure 17. Southeast Asia Medical Grade Chitosan Production Capacity (Ton), 2015-2026
Figure 18. Southeast Asia Medical Grade Chitosan Actual Output (Ton), 2015-2026
Figure 19. Southeast Asia Medical Grade Chitosan Production Value (US$, Mn), 2015-2026
Figure 20. The Percentage of Southeast Asia Medical Grade Chitosan Export Destination, 2019
Figure 21. The Source of Imports of Southeast Asia Medical Grade Chitosan, 2019
Figure 22. PEST Analysis for Southeast Asia Medical Grade Chitosan Market in 2020
Figure 23. Medical Grade Chitosan Market Opportunities & Trends in Southeast Asia
Figure 24. Medical Grade Chitosan Market Drivers in Southeast Asia
Figure 25. Medical Grade Chitosan Market Restraints in Southeast Asia
Figure 26. Medical Grade Chitosan Industry Value Chain